An anti-cancer medication might benefit early-stage patients of Alzheimer’s disease, according to a number of scientists. Millions of people around the world suffer from this incurable neuro degenerative disease that causes severe dementia and eventually destroys the entire nervous system. However, the latest discovery might make a difference to these patients. The scientists say that the drug helps patients learn new languages far more easily, perks up their short- and long-term memory and most significantly protects them from other forms of brain degeneration by remapping their nerves’ connections and preserving the current tissues. Alzheimer’s ravages the synapses, or the spaces interspersing the nerves through which tissues talk to one another and create memories. Medicines currently in use for the disease can relieve the symptoms but cannot stop its progress.